In an­oth­er blow to MSCs de­vel­op­er, Pluris­tem ter­mi­nates a failed lead pro­gram

A tough year for mes­enchy­mal stem cell com­pa­nies just got tougher.

Pluris­tem, the NASA-al­lied Is­raeli stem cell biotech, an­nounced Mon­day that a da­ta mon­i­tor­ing com­mit­tee …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.